EvaMarie J Introduction to the Blog Summary The blog explores the rise of GLP-1, a weight loss drug initially developed for diabetes management, and its impact on consumer behavior, with a focus on potential implications for brands in industries like food and beverages
[13] These findings are further reinforced by pharmacovigilance data from the FDA Adverse Event Reporting System (FAERS) database (n=48,214 reports), where GLP-1RA-related gastrointestinal adverse events, including nausea (9651 vs 38,030) and vomiting (4383 vs 17,062), were lower with combination therapy compared to GLP-1RA monotherapy, suggesting improved tolerability when metformin is added
Verge D, Lopez X
Gejalanya seperti tremor serta otot terasa kaku
Ive actually been sick less this year than in previous years. Patricia N
The women who keep their results treat the months on the medication as the window to build everything else